INCA Instituto Nacional de Cancer

Santo Cristo, Rio de Janeiro 20220-410

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery — Running, not enrolling